GentiBio

Biotechnology company · Cambridge, Massachusetts, United States

GentiBio is a biotechnology company headquartered in Cambridge, Massachusetts, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.2 million in total, most recently in 2025.

www.gentibio.comProfile compiled from public records. Is this your company? Request a correction or update

GentiBio at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Employees (self-reported, 2025)51

What does GentiBio do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $1.2 million in total (2025). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Institute of Diabetes and Digestive and Kidney Diseases.

Frequently asked questions about GentiBio

Where is GentiBio headquartered?

GentiBio is headquartered in Cambridge, Massachusetts, United States.

What does GentiBio do?

GentiBio is a biotechnology company.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences